» Authors » Yong Chan Kim

Yong Chan Kim

Explore the profile of Yong Chan Kim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 116
Citations 1629
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Hyun J, Song J, Park H, Yun I, Kwak Y, et al.
J Korean Med Sci . 2025 Mar; 40(9):e30. PMID: 40065713
Background: Differentiating between asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) is difficult in patients who have difficulty communicating their symptoms. This study aimed to evaluate the diagnostic accuracy of...
2.
Lee Y, Kim Y, Seong J, Ahn S, Han M, Lee J, et al.
J Microbiol Immunol Infect . 2025 Mar; PMID: 40059018
Background: Septic arthritis is frequently complicated by bloodstream infection (BSI), which can lead to metastatic infections and sepsis. In the current study, we aimed to identify risk factors for septic...
3.
Lee R, Huh K, Kang C, Kim Y, Kim J, Kim H, et al.
Infect Chemother . 2025 Feb; PMID: 39918228
pneumonia (PJP) is a life-threatening infection commonly observed in immunocompromised patients, necessitating prompt diagnosis and treatment. This review evaluates the diagnostic performance of various tests used for PJP diagnosis through...
4.
Jung K, Kim Y, Shin H, Park C
Sci Rep . 2025 Jan; 15(1):1952. PMID: 39809920
This retrospective study investigated the risk of primary open-angle glaucoma (POAG) among individuals identified as glaucoma suspects and examined associated cardiovascular risk factors. We conducted a longitudinal, nationwide cohort study...
5.
Nam H, Gong J, Kim Y, Nguyen-Phuong T, Byun N, Yoon J, et al.
Immune Netw . 2025 Jan; 24(6):e39. PMID: 39801740
Tregs play a central role in maintaining immune tolerance. Recent progress in the clinical application of Tregs underscores their potential for cell therapy. Nevertheless, a notable hurdle remains in producing...
6.
Yun I, Park H, Chae J, Kim Y, Kim B, Choi J
Infect Chemother . 2025 Jan; 56(4):557-558. PMID: 39762932
No abstract available.
7.
Chae J, Choi Y, Kim Y, Kim D
Infect Chemother . 2024 Oct; 56(4):461-472. PMID: 39431345
Background: Many pregnant women receive antibiotic treatment for infections. We investigated the association between quinolone use in the first trimester of pregnancy and the risk of adverse health outcomes for...
8.
Park S, Baek Y, Kim J, Seong H, Kim B, Kim Y, et al.
Infect Chemother . 2024 Sep; 56(3):308-328. PMID: 39231504
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The general section encompasses recommendations for the management...
9.
Seong Y, Song J, Lee E, Kim E, Heo J, Choi Y, et al.
BMC Infect Dis . 2024 Sep; 24(1):906. PMID: 39223521
Background: Glycopeptides for ampicillin-susceptible Enterococcus faecalis/faecium bacteremia are readily prescribed depending on the severity of the condition. However, there is limited data on the outcomes of glycopeptide use compared to...
10.
Gerelkhuu Z, Park S, Lee K, Kim Y, Kwon S, Song K, et al.
Immun Ageing . 2024 Jul; 21(1):51. PMID: 39080742
Background: Age-dependent immune responses to coronavirus disease 2019 (COVID-19) vaccinations and breakthrough infections (BIs) in young and middle-aged individuals are unclear. Methods: This nationwide multicenter prospective cohort study analyzed immune...